ESR1 and breast cancer: TMB expression was highest in TNBC patients, followed by HER2-positive patients, while TMB expression was lowest in patients with estrogen receptor- (ER-) positive, progesterone receptor- (PR-) positive, and human epidermal growth factor receptor-2- (HER2-) negative BC subtypes [20].